【结 构 式】 |
【分子编号】16152 【品名】(3R)-1-azabicyclo[2.2.2]octan-3-ol; (R)-(-)-Quinuclidinol 【CA登记号】42437-96-7 |
【 分 子 式 】C7H13NO 【 分 子 量 】127.18636 【元素组成】C 66.11% H 10.3% N 11.01% O 12.58% |
合成路线1
该中间体在本合成路线中的序号:(V)The alkylation of 2-phenylacetic acid (I) with 2-chloroethyl(methyl)sulfide (II) by means of lithium diisopropylamide (LDA) in THF gives 4-(methylsulfanyl)-2-phenylbutyric acid (III), which is esterified with methanol/H2SO4 yielding the methyl ester (IV). The transesterification of (IV) with quinuclidin-3(R)-ol (V) by means of NaH in refluxing toluene affords the 3(R)-quinuclidinyl ester (VI), which is hydroxymethylated with paraformaldehyde and NaH in DMF giving 2(RS)-(hydroxymethyl)-4-(methylsulfanyl)-2-phenylbutyric acid 3(R)-quinuclidinyl ester (VII) as a diastereomeric mixture. Chromatographic separation of (VII) over SiO2 using CHCl3/methanol/NH4OH as a gradient elution yields the 2(S)-hydroxymethyl isomer (VIII), which is oxidized with trifluoroperacetic acid in trifluoroacetic acid affording the corresponding sulfinyl derivative (IX) as a new diastereomeric mixture. Finally, this mixture is resolved by HPLC over Kromasil C-8 SiO2 using as eluant water/acetonitrile containing 1% trifluoroacetic acid.
【1】 Martel, A.M.; Rabasseda, X.; Castaner, J.; Revatropate. Drugs Fut 1997, 22, 2, 135. |
【2】 Cross, P.E.; Stobie, A. (Pfizer Inc.); Quinuclidine esters process and intermediate for their preparation and pharmaceutical compsns. containing them. EP 0603229; JP 1994510991; JP 1997315970; WO 9306098 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 16148 | Benzeneacetic acid; 2-Phenylacetic acid; Phenyl Acetic Acid | 103-82-2 | C8H8O2 | 详情 | 详情 |
(II) | 16149 | 2-Chloroethyl methyl sulfide; 1-Chloro-2-(methylsulfanyl)ethane | 542-81-4 | C3H7ClS | 详情 | 详情 |
(III) | 16150 | 4-(methylsulfanyl)-2-phenylbutyric acid | C11H14O2S | 详情 | 详情 | |
(IV) | 16151 | methyl 4-(methylsulfanyl)-2-phenylbutanoate | C12H16O2S | 详情 | 详情 | |
(V) | 16152 | (3R)-1-azabicyclo[2.2.2]octan-3-ol; (R)-(-)-Quinuclidinol | 42437-96-7 | C7H13NO | 详情 | 详情 |
(VI) | 16153 | (3R)-1-azabicyclo[2.2.2]oct-3-yl 4-(methylsulfanyl)-2-phenylbutanoate | C18H25NO2S | 详情 | 详情 | |
(VII) | 16154 | (3R)-1-azabicyclo[2.2.2]oct-3-yl 2-(hydroxymethyl)-4-(methylsulfanyl)-2-phenylbutanoate | C19H27NO3S | 详情 | 详情 | |
(VIII) | 16155 | (3R)-1-azabicyclo[2.2.2]oct-3-yl (2S)-2-(hydroxymethyl)-4-(methylsulfanyl)-2-phenylbutanoate | C19H27NO3S | 详情 | 详情 | |
(IX) | 16156 | (3R)-1-azabicyclo[2.2.2]oct-3-yl (2S)-2-(hydroxymethyl)-4-(methylsulfinyl)-2-phenylbutanoate | C19H27NO4S | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(VII)YM-905 has been obtained by two related ways: 1) The benzoylation of 2-phenylethylamine (I) with benzoyl chloride (II) and triethylamine in chloroform, or with benzoic acid (III), DPPA and triethylamine in DMF, gives the corresponding benzamide (IV), which is cyclized by means of POCl3 and P2O5 in refluxing xylene and reduced with NaBH4 in ethanol, yielding racemic 1-phenyl-1,2,3,4-tetrahydroisoquinoline (V). The reaction of (V) with ethyl chloroformate by means of K2CO3 in chloroform affords racemic 1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid ethyl ester (VI), which is transesterified with quinuclidine-3(R)-ol (VII) by means of NaH in refluxing toluene to provide the quinuclidinyl ester (VIII) as a diastereomeric mixture. This mixture is resolved by chiral HPLC, giving the target compound as a pure enantiomer. 2) The racemic 1-phenyl-1,2,3,4-tetrahydroisoquinoline (V) can also be submitted to optical resolution with (+)-tartaric acid to give 1(S)-phenyl-1,2,3,4-tetrahydroisoquinoline (IX), which is condensed with ethyl chloroformate by means of K2CO3 in chloroform to afford 1(S)-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid ethyl ester (VI). This compound is transesterified with quinuclidine-3(R)-ol (VII) by means of NaH in refluxing toluene to directly provide the pure enantiomer.
【1】 Mealy, N.; Castañer, J.; YM-905. Drugs Fut 1999, 24, 8, 871. |
【2】 Takeuchi, M.; Naito, R.; Hayakawa, M.; Okamoto, Y.; Yonetoku, Y.; Ikeda, K.; Isomura, Y. (Yamanouchi Pharmaceutical Co., Ltd.); Novel quinuclidine derivs. and medicinal compsn. thereof. EP 0801067; US 6017927; WO 9620194 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 18333 | Phenethylamine; 2-Phenyl-1-ethanamine | 64-04-0 | C8H11N | 详情 | 详情 |
(II) | 10463 | Benzoyl chloride | 98-88-4 | C7H5ClO | 详情 | 详情 |
(III) | 10202 | Benzoic acid | 65-85-0 | C7H6O2 | 详情 | 详情 |
(IV) | 26007 | N-phenethylbenzamide | C15H15NO | 详情 | 详情 | |
(V) | 26008 | 1-phenyl-1,2,3,4-tetrahydroisoquinoline | C15H15N | 详情 | 详情 | |
(VI) | 26009 | ethyl 1-phenyl-3,4-dihydro-2(1H)-isoquinolinecarboxylate | C18H19NO2 | 详情 | 详情 | |
(VII) | 16152 | (3R)-1-azabicyclo[2.2.2]octan-3-ol; (R)-(-)-Quinuclidinol | 42437-96-7 | C7H13NO | 详情 | 详情 |
(VIII) | 26010 | (3R)-1-azabicyclo[2.2.2]oct-3-yl 1-phenyl-3,4-dihydro-2(1H)-isoquinolinecarboxylate | C23H26N2O2 | 详情 | 详情 | |
(IX) | 26011 | (1S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline | C15H15N | 详情 | 详情 | |
(X) | 26012 | ethyl (1S)-1-phenyl-3,4-dihydro-2(1H)-isoquinolinecarboxylate | C18H19NO2 | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:(VII)
【1】 Naito R. Yonetoku Y, Okamoto Y, et aL. 2005. Synthesis and antimuscarinic properties of quinuclidin-3-yl 1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives as novel muscarinic receptor antagonists. J Med Chem, 48(21):6597~6606 |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 26007 | N-phenethylbenzamide | C15H15NO | 详情 | 详情 | |
(II) | 66735 | 1-phenyl-3,4-dihydroisoquinoline | 52250-50-7 | C15H13N | 详情 | 详情 |
(III) | 66736 | 1-phenyl-1,2,3,4-tetrahydroisoquinoline | C15H15N | 详情 | 详情 | |
(IV) | 66737 | C15H15N.C4H6O6 | 详情 | 详情 | ||
(V) | 26011 | (1S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline | C15H15N | 详情 | 详情 | |
(VI) | 26012 | ethyl (1S)-1-phenyl-3,4-dihydro-2(1H)-isoquinolinecarboxylate | C18H19NO2 | 详情 | 详情 | |
(VII) | 16152 | (3R)-1-azabicyclo[2.2.2]octan-3-ol; (R)-(-)-Quinuclidinol | 42437-96-7 | C7H13NO | 详情 | 详情 |
合成路线4
该中间体在本合成路线中的序号:(III)
【1】 Perlman N, Nidam T. 2007. Processes for preparation of solifenacin. W0 2007076116 |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 26011 | (1S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline | C15H15N | 详情 | 详情 | |
(II) | 66739 | (R)-2-chloroethyl 1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate | C18H18ClNO2 | 详情 | 详情 | |
(III) | 16152 | (3R)-1-azabicyclo[2.2.2]octan-3-ol; (R)-(-)-Quinuclidinol | 42437-96-7 | C7H13NO | 详情 | 详情 |
(IV) | 66740 | (R)-2-chloroethyl quinuclidin-3-yl carbonate | C10H16ClNO3 | 详情 | 详情 |
合成路线5
该中间体在本合成路线中的序号:(VIII)
【1】 Daeniker HU, Grob CA. 1964. 3-Quinuclidone hydrochloride. Org Syn, 44: 86~90 |
【2】 Han XY, Liu H, Liu CH, et al. 2005. Synthesis of the optical rsomers of a new anticholinergic drug, penehyclidine hydrochloride (8018). Bioorg Med Chemm lett, 15(8):1979~1982 |
【3】 Ji JG, Li T. 2005. Preparatum of bicycloheterocyclyl substituted quiniculidine derivatives for use in pharmaceutical compositions which modulate the effects of α 7 nicotinic acetylcholine receptors(α 7 nAChR). US 2005137184 |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 43671 | ethyl isonicotinate | 1570-45-2 | C8H9NO2 | 详情 | 详情 |
(II) | 66741 | 1-(2-ethoxy-2-oxoethyl)-4-(ethoxycarbonyl)pyridin-1-ium bromide | C12H16BrNO4 | 详情 | 详情 | |
(III) | 66742 | ethyl 1-(2-ethoxy-2-oxoethyl)piperidine-4-carboxylate | 1838-39-7 | C12H21NO4 | 详情 | 详情 |
(IV) | 66743 | ethyl 3-oxoquinuclidine-2-carboxylate | C10H15NO3 | 详情 | 详情 | |
(V) | 66744 | quinuclidin-3-one hydrochloride | C7H11NO.HCl | 详情 | 详情 | |
(VI) | 66745 | quinuclidin-3-ol | C7H13NO | 详情 | 详情 | |
(VII) | 66746 | quinuclidin-3-yl acetate | C9H15NO2 | 详情 | 详情 | |
(VIII) | 16152 | (3R)-1-azabicyclo[2.2.2]octan-3-ol; (R)-(-)-Quinuclidinol | 42437-96-7 | C7H13NO | 详情 | 详情 |